Meningioma 1 anticorps (Middle Region)
Aperçu rapide pour Meningioma 1 anticorps (Middle Region) (ABIN953469)
Antigène
Voir toutes Meningioma 1 (MN1) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 842-872, Middle Region
-
Specificité
- This antibody recognizes Human MN1 (Center).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 842-872 amino acids from the Central region of human MN1.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
-
Autre désignation
- MN1
-
Sujet
- Meningioma 1 (MN1) contains two sets of CAG repeats. It is disrupted by a balanced translocation (4,22) in a meningioma, and its inactivation may contribute to meningioma 32 pathogenesis.Synonyms: Probable tumor suppressor protein MN1, meningioma 1
-
Poids moléculaire
- 136001 Da
-
ID gène
- 4330
-
NCBI Accession
- NP_002421
Antigène
-